How to buy VBI Vaccines stock | $3.15

VBI Vaccines Inc is a biotechnology business based in the US. VBI Vaccines shares (VBIV) are listed on the NASDAQ and all prices are listed in US Dollars. VBI Vaccines employs 127 staff and has a trailing 12-month revenue of around 0.00.

VBI Vaccines share price

Use our graph to track the performance of VBIV stocks over time.

VBI Vaccines shares at a glance

• Key figures

Information last updated 2021-05-14.

Latest market close	$3.15
52-week range	$1.85 - $6.93
50-day moving average	$2.92
200-day moving average	$3.10
Wall St. target price	$7.50
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	$-0.76

Buy VBI Vaccines shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

Is it a good time to buy VBI Vaccines stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of VBI Vaccines Inc by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

VBI Vaccines price performance over time

Historical closes compared with the close of $3.15 from 2021-03-10

1 week (2021-05-07)	13.31%
1 month (2021-04-15)	8.62%
3 months (2021-02-12)	-19.02%
6 months (2020-11-13)	17.54%

1 year (2020-05-15)	66.67%
2 years (2019-05-15)	52.91%
3 years (2018-05-15)	3.25
5 years (2016-05-13)	4

VBI Vaccines financials

Revenue TTM	$947,000
Gross profit TTM	$-8,107,000
Return on assets TTM	-18.89%
Return on equity TTM	-43.64%
Profit margin	0%
Book value	$0.71
Market capitalisation	$727 million

TTM: trailing 12 months

Shorting VBI Vaccines shares

There are currently 37.7 million VBI Vaccines shares held short by investors – that's known as VBI Vaccines's "short interest". This figure is 4.1% down from 39.3 million last month.

There are a few different ways that this level of interest in shorting VBI Vaccines shares can be evaluated.

VBI Vaccines's "short interest ratio" (SIR)

VBI Vaccines's "short interest ratio" (SIR) is the quantity of VBI Vaccines shares currently shorted divided by the average quantity of VBI Vaccines shares traded daily (recently around 3.1 million). VBI Vaccines's SIR currently stands at 12.05. In other words for every 100,000 VBI Vaccines shares traded daily on the market, roughly 12050 shares are currently held short.

However VBI Vaccines's short interest can also be evaluated against the total number of VBI Vaccines shares, or, against the total number of tradable VBI Vaccines shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case VBI Vaccines's short interest could be expressed as 0.15% of the outstanding shares (for every 100,000 VBI Vaccines shares in existence, roughly 150 shares are currently held short) or 0.2044% of the tradable shares (for every 100,000 tradable VBI Vaccines shares, roughly 204 shares are currently held short).

A SIR above 10% would generally be considered pretty high, pointing to a potentially pessimistic outlook for the share price and a discouraging interest in betting against VBI Vaccines.

Find out more about how you can short VBI Vaccines stock.

VBI Vaccines share dividends

We're not expecting VBI Vaccines to pay a dividend over the next 12 months.

Have VBI Vaccines's shares ever split?

VBI Vaccines's shares were split on a 1:40 basis on 1 May 2016. So if you had owned 40 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your VBI Vaccines shares – just the quantity. However, indirectly, the new 3900% higher share price could have impacted the market appetite for VBI Vaccines shares which in turn could have impacted VBI Vaccines's share price.

VBI Vaccines share price volatility

Over the last 12 months, VBI Vaccines's shares have ranged in value from as little as $1.85 up to $6.93. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while VBI Vaccines's is 1.9984. This would suggest that VBI Vaccines's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

VBI Vaccines overview

VBI Vaccines Inc. , a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The company's enveloped virus-like particle (eVLP) platform technology allows for the development of eVLP vaccines that mimic the presentation of viruses to elicit a human immune system. Its lead eVLP program candidates include VBI-1901, a glioblastoma vaccine immunotherapeutic candidate, which is in Phase I/IIa clinical study; and VBI-1501, a prophylactic cytomegalovirus vaccine candidate that has completed Phase I clinical trial. The company also develops coronavirus vaccine candidates, such as VBI-2902 and VBI-2901.

Frequently asked questions

• What percentage of VBI Vaccines is owned by insiders or institutions?

  Currently 3.274% of VBI Vaccines shares are held by insiders and 53.916% by institutions.

• How many people work for VBI Vaccines?

  Latest data suggests 127 work at VBI Vaccines.

• When does the fiscal year end for VBI Vaccines?

  VBI Vaccines's fiscal year ends in December.

• Where is VBI Vaccines based?

  VBI Vaccines's address is: 222 Third Street, Cambridge, MA, United States, 02142

• What is VBI Vaccines's ISIN number?

  VBI Vaccines's international securities identification number is: CA91822J1030

• What is VBI Vaccines's CUSIP number?

  VBI Vaccines's Committee on Uniform Securities Identification Procedures number is: 91822J103